Cite
MLA Citation
Fabien Zoulim et al.. “Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial.” Human vaccines & immunotherapeutics, vol. 16, no. 2, 2020, pp. 388–399. http://access.bl.uk/ark:/81055/vdc_100101654053.0x000010